Assure Holdings Signs Letter of Intent to Purchase Certain Assets of Innovation Neuromonitoring, LLC
DENVER, June 26, 2023 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, today announced that it has signed a Letter of Intent (“LOI”) to purchase certain assets of Innovation Neuromonitoring, LLC (“Innovation”) for approximately $1.2 million in a cash and equity transaction.
- DENVER, June 26, 2023 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, today announced that it has signed a Letter of Intent (“LOI”) to purchase certain assets of Innovation Neuromonitoring, LLC (“Innovation”) for approximately $1.2 million in a cash and equity transaction.
- Established in 2016, Innovation is a leading IONM company primarily serving the Greater Dallas, Texas and Charleston, South Carolina regions.
- In 2022, Innovation performed more than 4,000 IONM procedures and approximately 51% of these procedures were with commercial insurance payors.
- The proposed Acquisition will take the form of either an asset or equity purchase by Assure at its choice at closing.